We have a real-world evidence registry called Falcon, where we're enrolling up to 25,000 individuals who receive annual Cancerguard testing over three years. Our modeling studies suggest that if you ...

Research presented at ENDO 2025 revealed that obesity-related cancer deaths in the U.S. have tripled over the past two decades. Thirteen types of obesity-related cancers now account for 40% of all ...

OpEd: Multicancer early detection is the next frontier in cancer prevention and treatment, and it needs to be adopted widely.

Panelists discuss how promising ongoing and upcoming clinical trials may reshape sequencing strategies in ALK+ non–small cell lung cancer (NSCLC). The panelists collectively addressed the evolving ...

Bi- and multi-specific antibodies hold enormous promise for the next generation of precision cancer immunotherapies as they enable novel mechanisms of action such as redirecting T cell activation, ...

Cancer imaging is entering a phase where malignant cells no longer hide in murky grayscale but flare into view with surgical precision. Across operating rooms, scanners, and even blood tests, ...

Ovarian cancer remains one of the most difficult-to-treat diseases. With all our advances in screening and molecular profiling, it still maintains the worst death-to-diagnosis rate among gynecologic ...

Approximately 25-30% of lung cancer patients lack mutations targeted by current therapies, necessitating novel approaches. New targets, including MTAP deletions, SMARC4, and p53 mutations, show ...

Covid vaccines may come with a tantalizing benefit that has nothing to do with the virus they’re designed to protect against: boosting the immune system to better fight tumors during cancer treatment.

More inherited genes for cancer have been discovered at Huntsman Cancer Institute than anywhere else in the world—thanks to one of our most valuable resources, the Utah Population Database (UPDB).